BackLupin launches generic Tadalafil tablets in US
The product is a generic version of Eli Lilly's Adcirca tablets in the same strength It is indicated for the treatment of pulmonary arterial hypertension (PAH) to improve exercise ability
PremiumNEW DELHI : Drug firm Lupin Tuesday said it has launched generic Tadalafil tablets used for the treatment of pulmonary arterial hypertension in the American market.
The company has launched Tadalafil tablets USP in the strength of 20 mg after having received an approval for them from the United States Food and Drug Administration (USFDA) earlier, Lupin said in a filing to BSE.
The product is a generic version of Eli Lilly's Adcirca tablets in the same strength, it added.
It is indicated for the treatment of pulmonary arterial hypertension (PAH) to improve exercise ability.
As per IQVIA MAT December 2018 data, the Tadalafil tablets, 20 mg had annual sales of around USD 474.3 million in the US.
Shares of Lupin Ltd closed at ₹812.85 per scrip on BSE, down 0.78 per cent from its previous close.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!
This story has been published from a wire agency feed without modifications to the text.
